Gregory J Dore Selected Research

Antiviral Agents (Antivirals)

2/2024	Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
2/2024	Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination.
1/2023	A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.
1/2023	Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
1/2023	Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection.
1/2023	Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
1/2023	Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C).
1/2023	National trends in retreatment of HCV due to reinfection or treatment failure in Australia.
12/2022	Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.
11/2022	Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory J Dore Research Topics

Disease

150	Infections 04/2024 - 05/2000
59	Hepatitis C 04/2024 - 07/2005
36	Fibrosis (Cirrhosis) 05/2022 - 03/2005
32	Coinfection 12/2023 - 10/2003
29	Reinfection 04/2024 - 10/2009
29	Chronic Hepatitis C 01/2022 - 10/2003
22	Liver Diseases (Liver Disease) 02/2024 - 12/2007
12	Hepatitis B 03/2024 - 07/2004
11	COVID-19 03/2024 - 01/2021
10	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 03/2005
10	HIV Infections (HIV Infection) 02/2016 - 12/2003
9	Hepatitis 10/2023 - 05/2004
8	Disease Progression 01/2019 - 10/2003
5	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 09/2008
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2011 - 04/2002
4	Substance-Related Disorders (Drug Abuse) 05/2023 - 01/2021
4	Persistent Infection 01/2023 - 09/2014
4	Blister (Bulla) 10/2020 - 01/2018
4	Viremia 01/2019 - 10/2010
3	Chronic Hepatitis B 12/2020 - 01/2010
3	Virus Diseases (Viral Diseases) 01/2020 - 09/2011
2	Opioid-Related Disorders (Opiate Addiction) 03/2024 - 01/2022
2	Cognitive Dysfunction 01/2024 - 01/2023
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2018
2	Nausea 12/2018 - 01/2017
2	Headache (Headaches) 01/2017 - 08/2014
2	Fatigue 01/2017 - 08/2014
2	Anemia 06/2014 - 04/2011
2	Neoplasms (Cancer) 12/2012 - 05/2009
2	Superinfection 04/2012 - 11/2010
2	AIDS Dementia Complex 07/2003 - 04/2002
1	Tetanus 03/2024
1	Hepatitis A (Hepatitis, Infectious) 03/2024
1	Pneumococcal Infections 03/2024
1	Human Influenza (Influenza) 03/2024

Drug/Important Bio-Agent (IBA)

83	Antiviral Agents (Antivirals)IBA 02/2024 - 10/2003
44	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2004
40	InterferonsIBA 01/2023 - 03/2005
31	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 07/2007
17	Opioid Analgesics (Opioids)IBA 11/2023 - 07/2007
16	VaccinesIBA 03/2024 - 03/2007
15	SofosbuvirIBA 10/2021 - 08/2015
9	AntigensIBA 04/2024 - 01/2007
9	Alanine Transaminase (SGPT)IBA 10/2023 - 04/2007
9	velpatasvirIBA 10/2021 - 12/2015
7	glecaprevir and pibrentasvirIBA 10/2023 - 01/2017
6	daclatasvirIBA 10/2019 - 02/2015
6	peginterferon alfa-2a (Pegasys)FDA Link 02/2015 - 07/2007
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 05/2016 - 05/2000
5	CytokinesIBA 02/2016 - 11/2012
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2014 - 06/2004
5	Tenofovir (Viread)FDA Link 05/2013 - 01/2007
5	Hepatitis B e AntigensIBA 01/2013 - 01/2007
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 04/2008
4	Interferon LambdaIBA 01/2022 - 11/2014
4	telaprevirIBA 01/2016 - 11/2011
4	Heroin (Diamorphine)IBA 10/2014 - 01/2014
3	Hepatitis C AntibodiesIBA 04/2024 - 10/2010
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2012
3	EnzymesIBA 01/2023 - 11/2012
3	ombitasvirIBA 10/2020 - 11/2018
3	dasabuvirIBA 10/2020 - 11/2018
3	paritaprevirIBA 10/2020 - 11/2018
3	Ritonavir (Norvir)FDA Link 10/2020 - 11/2018
3	sofosbuvir drug combination ledipasvirIBA 01/2018 - 12/2016
3	Interferon-gamma (Interferon, gamma)IBA 01/2016 - 01/2013
3	Interferon-alpha (Interferon Alfa)IBA 10/2014 - 10/2009
3	Lamivudine (Epivir)FDA Link 01/2010 - 01/2007
2	Immunoglobulin G (IgG)IBA 04/2024 - 08/2022
2	Buprenorphine (Subutex)FDA LinkGeneric 03/2024 - 01/2022
2	Illicit Drugs (Recreational Drugs)IBA 02/2024 - 01/2017
2	nafamostatIBA 11/2023 - 10/2022
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2023 - 01/2014
2	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 05/2022 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2017
2	grazoprevirIBA 06/2020 - 11/2016
2	elbasvirIBA 06/2020 - 11/2016
2	glecaprevirIBA 01/2018 - 01/2017
2	pibrentasvirIBA 01/2018 - 01/2017
2	NucleotidesIBA 01/2017 - 05/2016
2	ChemokinesIBA 02/2016 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 09/2014
2	LipidsIBA 01/2016 - 03/2010
2	Transaminases (Aminotransferases)IBA 01/2016 - 12/2013
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2014 - 11/2011
2	SimeprevirIBA 08/2014 - 12/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2014 - 06/2012
2	RacivirIBA 01/2010 - 08/2009

Therapy/Procedure

100	Therapeutics 02/2024 - 10/2003
17	Opiate Substitution Treatment 01/2022 - 07/2005
9	Highly Active Antiretroviral Therapy (HAART) 01/2013 - 04/2002
8	Retreatment 02/2024 - 11/2017
4	Injections 03/2024 - 01/2021
4	Liver Transplantation 11/2021 - 03/2005
4	Duration of Therapy 12/2016 - 03/2011
2	Aftercare (After-Treatment) 01/2022 - 01/2022
2	Ambulatory Care (Outpatient Care) 01/2020 - 04/2011
2	Drug Therapy (Chemotherapy) 10/2015 - 07/2007
2	Tattooing 10/2010 - 09/2007